Ortataxel Completed Phase 2 Trials for Lung Cancers Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00054314BAY 59-8862 in Treating Patients With Non-Small Cell Lung Cancer